GSK has announced a licensing agreement with Hyderabad, India-based Bharat Biotech for its Shigella vaccine candidate, altSonflex 1-2-3. This collaboration signifies a step in addressing the global burden of Shigella, a bacterial infection that causes severe diarrhea and is responsible for thousands of deaths annually, predominantly among children under five....
India’s Pharmaceutical Industry Moves Toward Biosimilars, Med Tech
The Indian pharmaceutical industry, long hailed as the 'pharmacy of the world,' is undergoing a significant transformation. While it continues to be a major contributor to India's economic growth, the sector is rapidly shifting its focus from generic drugs to more advanced areas such as MedTech and biosimilars. MedTech focuses...
New Delhi-Based Panacea Biotec Wins $127 Million Contract
Vaccine maker Panacea Biotec received a long-term supply contract worth over $127 million from UNICEF and the Pan American Health Organization (PAHO) for supply of its WHO pre-qualified fully liquid pentavalent vaccine, Easyfive-TT (DTwP-HepB-Hib). This vaccine protects children against five deadly diseases: Diphtheria, Tetanus, Pertussis, Hepatitis B and invasive infections...
15-Year-Old in India Innovates “Green Wood”
Watching the mounds of grain chaff burning at her family’s farm in India’s northern city of Amritsar, the then 15-year-old Bisman Deu decided to research the pollution caused by this activity. “I started researching pollution,” she says, “then I researched the properties of rice husk; it has a high silica...